Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

HIV can cause unusual and severe skin problems that are hard to treat.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Minoxidil doesn't increase pericardial disorder risk, but may cause fluid accumulation.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Hair follicles offer promising targets for delivering drugs to treat hair and skin conditions.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Captopril reduces heart mass, while minoxidil has opposite effects and side effects.

A hair wrapped tightly around an infant's toe caused severe damage, requiring early removal and possibly surgery to prevent worse outcomes like amputation.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.